Görlach Agnes, BelAiba Rachida S, Hess John, Kietzmann Thomas
Experimental Pediatric Cardiology, Department of Pediatric Cardiology and Congenital Heart Disease, German Heart Center Munich at the Technical University Munich, Lazarettstrasse 36 , 80636 Munich, Germany.
Thromb Haemost. 2005 Jun;93(6):1168-75. doi: 10.1160/TH05-01-0006.
The p21-activated serine/threonine kinases (PAK) play an important role in a variety of cellular functions. However, their role in the smooth muscle response to thrombin, which is activated upon vascular injury and promotes vascular remodelling processes, is not resolved. Here we investigated the role of PAK in thrombin signalling and regulation of tissue factor (TF), the activator of the extrinsic coagulation cascade, in pulmonary artery smooth muscle cells (PASMC), the main cell type responsible for vascular remodelling in pulmonary hypertension. PAK was rapidly phosphorylated in response to thrombin. Thrombin and active PAKT423E phosphorylated p38 MAP kinase (p38MAPK), ERK1/2, phosphatidylinositol-dependent kinase-1 (PDK1) and protein kinase B/Akt (PKB) whereas kinase-deficient PAK1 prevented activation of these kinases by thrombin. In addition, kinase- deficient MKK3 inhibited activation of PDK1 and PKB by thrombin. Further, thrombin and active PAK1 induced TF expression and promoter activity while kinase-deficient PAK1 diminished thrombin-induced TF upregulation. Moreover, kinase-deficient MKK3, PDK1 and PKB inhibited thrombin- and PAK-dependent TF expression and promoter activity. Together these findings show that PAK is a critical element of thrombin signalling in PASMC which is involved in the regulation of TF expression by sequentially activating MKK3/p38MAPK, PDK1 and PKB. Thus, PAK may play an important role in promoting vascular remodelling processes in pulmonary hypertension.
p21激活的丝氨酸/苏氨酸激酶(PAK)在多种细胞功能中发挥重要作用。然而,它们在平滑肌对凝血酶的反应中的作用尚未明确,凝血酶在血管损伤时被激活并促进血管重塑过程。在这里,我们研究了PAK在肺动脉平滑肌细胞(PASMC)中凝血酶信号传导和组织因子(TF)调节中的作用,PASMC是肺动脉高压中负责血管重塑的主要细胞类型。PAK对凝血酶反应迅速发生磷酸化。凝血酶和活性PAKT423E使p38丝裂原活化蛋白激酶(p38MAPK)、细胞外信号调节激酶1/2(ERK1/2)、磷脂酰肌醇依赖性激酶-1(PDK1)和蛋白激酶B/蛋白激酶B(PKB)磷酸化,而激酶缺陷型PAK1可阻止凝血酶对这些激酶的激活。此外,激酶缺陷型MKK3抑制凝血酶对PDK1和PKB的激活。此外,凝血酶和活性PAK1诱导TF表达和启动子活性,而激酶缺陷型PAK1减少凝血酶诱导的TF上调。此外,激酶缺陷型MKK3、PDK1和PKB抑制凝血酶和PAK依赖性TF表达及启动子活性。这些发现共同表明,PAK是PASMC中凝血酶信号传导的关键元件,通过依次激活MKK3/p38MAPK、PDK1和PKB参与TF表达的调节。因此,PAK可能在促进肺动脉高压中的血管重塑过程中发挥重要作用。